Armaan Dhanda
Co-Founder Anomaly Bio
Armaan Dhanda is the co-founder of Anomaly Bio, a Singapore-based startup that turns microbes into micro-factories to rebuild ingredient supply chains. Anomaly has raised $2.6 million in a pre-seed round involving notable angels such as Akshay Kothari (Notion) and Sean Hunt (Solugen) and was one of five startups selected for The Next Generation Pet Food Program by Mars Petcare and Big Idea Ventures. Armaan’s on a leave of absence from NUS where he was reading Chemical Engineering on the fully-funded S&T Scholarship.
Seminars
Tuesday 23rd June 2026
A Default-Alive Biomanufacturing Company
11:45 am
- The Strategic Importance of Biomanufacturing: Biomanufacturing is a first-order priority for food security and public health, moving essential production from farms and petrochemical plants into fermenters using engineered microbes or enzymes
- Evolution of the Industry: Comparing “Gen 1” companies (like Ajinomoto), which prioritized manufacturing efficiency and luck-driven applications, with “Gen 2” companies (like Amyris), which focused on engineering biology but struggled with high capital requirements and in-house infrastructure
- The New Operating Model: Exploring how to combine Gen 2 engineering capabilities with Gen 1 manufacturing scale to build biomanufacturing companies that remain “default-alive” and commercially viable
